Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
Alerts
News
Cancer Hallmarks
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
Cancer Hallmarks
Webinars

Skip Nav Destination

Article navigation

Volume 10, Issue 12

15 June 2004

Previous Article
Next Article

Supplement Articles| June 15 2004

CME Post-test and Evaluation

Author & Article Information

Online ISSN: 1557-3265

Print ISSN: 1078-0432

2004

Clin Cancer Res (2004) 10 (12): 4285s.

https://doi.org/10.1158/1078-0432.CCR-040024

Split-Screen
Views
Open the PDF for in another window
Share
- Facebook
- Twitter
- LinkedIn
- Email
Tools
- Get Permissions
- Cite
Search Site
Versions
- Version of Record June 15 2004

Citation

CME Post-test and Evaluation. Clin Cancer Res 15 June 2004; 10 (12): 4285s. https://doi.org/10.1158/1078-0432.CCR-040024

Download citation file:

Ris (Zotero)
Reference Manager
EasyBib
Bookends
Mendeley
Papers
EndNote
RefWorks
BibTex

toolbar search

toolbar search

search input Search input auto suggest

Search

Advanced Search

Fig. 1.

View large Download slide

Fig. 1.

View large Download slide

2004

244 Views

View Metrics

×

Citing articles via

Google Scholar

Advertisement

Email alerts

Article Activity Alert

Online First Alert

eTOC Alert

Breaking

Tafasitamab Lowers Risk of Follicular Lymphoma Progression

9/11 First Responders Have Twofold Increase in Leukemia Precursor

Daratumumab Can Prevent Progression of Myeloma Precursor

View more recent articles

Latest News

Imlunestrant Delays Progression in Some Breast Cancers

“Digital Twins” May Improve Treatment Prediction

Prevention and Screening Preclude 80% of Cancer Deaths

View more recent articles

Research Watch

The Liver X Receptor Axis Balances Intestinal Regeneration and Tumorigenesis

Oncolytic Virotherapy Plus Nivolumab Is Safe in Muscle-Invasive Bladder Cancer

Specialized Fibroblasts Shape T-Cell Environments in Lung Cancer

View more recent articles

Latest
Most Read
Most Cited

A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer

Sacituzumab Govitecan in Patients With Relapsed/Refractory Advanced Head and Neck Squamous Cell Carcinoma: Results From the Phase 2 TROPiCS-03 Basket Study

A Phase 1 Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients With Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors

Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer

Issues
Online First
Collections

News
Twitter

Online ISSN 1557-3265
Print ISSN 1078-0432

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Information on Advertising & Reprints
Information for Institutions/Librarians
RSS Feeds
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2023 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept